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Abstract: 3'-5'-cyclic adenosine monophosphate (cAMP) is a second messenger,  
which plays an important role in the heart. It is generated in response to activation of  
G-protein-coupled receptors (GPCRs). Initially, it was thought that protein kinase A (PKA) 
exclusively mediates cAMP-induced cellular responses such as an increase in cardiac 
contractility, relaxation, and heart rate. With the identification of the exchange factor 
directly activated by cAMP (EPAC) and hyperpolarizing cyclic nucleotide-gated (HCN) 
channels as cAMP effector proteins it became clear that a protein network is involved in 
cAMP signaling. The Popeye domain containing (Popdc) genes encode yet another family 
of cAMP-binding proteins, which are prominently expressed in the heart. Loss-of-function 
mutations in mice are associated with cardiac arrhythmia and impaired skeletal muscle 
regeneration. Interestingly, the cardiac phenotype, which is present in both, Popdc1 and 
Popdc2 null mutants, is characterized by a stress-induced sinus bradycardia, suggesting 
that Popdc proteins participate in cAMP signaling in the sinuatrial node. The identification 
of the two-pore channel TREK-1 and Caveolin 3 as Popdc-interacting proteins represents a 
first step into understanding the mechanisms of heart rate modulation triggered by  
Popdc proteins. 
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1. Introduction 
The second messenger cyclic adenosine 3', 5' monophosphate (cAMP) plays a prominent role in 
cardiac physiology and signal transduction. cAMP is produced by adenylate cyclase (AC). There are 
ten different AC, nine of which are membrane-bound (AC1-9) and activated by G protein-coupled 
receptors (GPCRs) or by Ca2+ (Figure 1) [1]. The tenth AC is soluble (sAC) and is regulated by 
bicarbonate [2]. AC5 and -6 are the major isoforms present in cardiac myocytes and are coupled for 
example to adrenergic and cholinergic receptors through stimulatory and inhibitory Gα-subunits. Once 
activated, AC produces a large amount of cAMP, which passively diffuses in cells. cAMP is rapidly 
degraded by phosphodiesterases, which thereby ensure that cAMP diffusion is limited and usually 
confined to a small area around the site of production. There are three cAMP effector protein classes 
known: protein kinase A (PKA), exchange factor directly activated by cAMP (EPAC), and cyclic 
nucleotide-activated ion channels, which includes cyclic nucleotide–gated (CNG) channels, mainly 
expressed in photoreceptors and olfactory sensory neurons, and hyperpolarization-activated cyclic 
nucleotide-gated (HCN) channels, which are expressed in heart and brain [3]. We recently discovered 
a fourth class of cAMP-binding proteins, the Popeye domain containing proteins (Popdc), which are 
the main focus of this review article [4–7]. A fifth potential cAMP-binding protein, Cris was recently 
identified, which however is exclusively expressed in sperm precursor cells [8]. 
2. The Popeye Domain Containing Proteins 
The Popeye domain containing (Popdc) genes were discovered 15 years ago after screening cardiac 
cDNA libraries with the goal to identify genes with a cardiac-enriched expression pattern [9,10]. 
Immunohistochemistry, in situ hybridization, LacZ staining of knock-in reporter genes and RT-PCR 
established an exclusive expression in cardiac myocytes [4,10–13]. This expression pattern is 
evolutionary conserved [14–16]. 
There are three Popdc genes in vertebrates, Popdc1 (also known as Bves), Popdc2 and Popdc3 [10]. 
Popdc genes encode small membrane-localized proteins, which are between 290–360 amino acids 
long. They have three transmembrane domains and in the cytoplasmic part of the protein, a highly 
conserved Popeye domain is present [10]. Popdc proteins are unique and do not resemble any other 
non-Popdc protein. The proteins with the highest sequence similarity are the bacterial cAMP regulator 
proteins (CRP) [6], which encode transcription factors that modulate gene expression in response to 
metabolic changes [17]. While a transcriptional regulatory role has yet to be demonstrated for Popdc 
proteins, both Popdc1 and Popdc2 have been found in the nucleus of striated muscle cells in addition 
to their presence at the plasma membrane [18].  
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Figure 1. Schematic overview of the elements of the cAMP signal transduction pathway in 
cardiac myocytes. G-protein coupled receptors (GPCRs) such as the β-adrenergic receptor 
activate Gαs causing a stimulation of cAMP production by adenylate cyclase (AC). Other 
GPCRs such as the muscarinic acetylcholine receptor couple with GαI causing an inhibition 
of AC. cAMP production is highly controlled in a spatiotemporal manner. Main control of 
compartmentalization is through the rapid degradation of cAMP by phosphodiesterases (PDE) 
which hydrolyzes cAMP to adenosine monophosphate (AMP). PDE are often present in 
close neighborhood with protein kinase A (PKA) through association with A kinase  
anchor proteins (AKAP) proteins, which are responsible for localizing PKA to different 
compartments in the cell. Other cAMP-binding domain (CNBD) containing proteins are the 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which play a major 
player in cardiac pacemaking. The exchange factor directly activated by cAMP (EPAC) is 
a guanine nucleotide exchange factor, which modulates Ras related protein 1 (Rap1), a 
small GTP-binding protein. The Popeye domain containing (Popdc) proteins represent yet 
another class of cAMP-binding proteins, which play an important role in cardiac pacemaking. 
Popdc proteins interact with the two-pore potassium ion channel TWIK related K-1 
(TREK-1) and Caveolin 3 (Cav-3) [4,19]. For each cAMP effector protein a few examples 
of functions in striated muscle tissue are given in the white boxes adjacent to each 
molecule. It becomes apparent that the cAMP-binding proteins display significant functional 
overlap. It should also be mentioned that different cardiac muscle cells differ in the level of 
expression of some the depicted effector proteins. For example, the sinuatrial (SAN) and 
atrioventricular (AVN) nodes express higher levels of HCN1 and HCN4 and Popdc1 and 
Popdc2 than atrial and ventricular muscle cells.  
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The Popeye domain displays significant structural homology to cAMP-binding proteins [4].  
A homology model was devised and is based on structural information of CRP and PKA. This model 
revealed that a large fraction of invariant amino acids cluster around the putative cAMP-binding domain 
suggesting their involvement in nucleotide binding [4,6,7]. Indeed, for a number of these conserved 
residues, mutagenesis revealed an essential function in cAMP-binding. In particular, the aspartate 
residues D200 in Popdc1 and D184 in Popdc2 appear to be essential for nucleotide binding [4,6,7]. 
Surprisingly the protein sequence of the phosphate-binding cassette (PBC) is unique and different from 
that of HCN4, EPAC, or PKA [6,7]. This suggests an independent evolution of the PBC of Popdc 
proteins. Surprisingly, the PBC of Popdc proteins found in basic metazoans such as cniderians (Hydra) 
is almost identical to the PBC found in Popdc proteins from higher vertebrates [6] demonstrating 
strong evolutionary pressure to retain these sequences and providing further evidence for their 
functional importance. Affinity measurements revealed that Popdc proteins bind cyclic nucleotides 
with high affinity in the physiologically relevant range [4]. 
3. Loss-of-Function Mutations of Popeye Domain Containing Genes are Causing  
Cardiac Arrhythmia 
All three members of the Popdc family are abundantly expressed in cardiac and skeletal muscle. 
Loss-of-function experiments in zebrafish using morpholino-mediated knockdown caused defective 
development of skeletal muscle in the head and trunk [14]. While muscle development is apparently 
normal in mice, there is a retarded ability of skeletal muscle regeneration [11]. In the zebrafish heart of 
popdc2 morphants, a severe atrioventricular block is observed [14]. Interestingly, a cardiac arrhythmia 
phenotype is also found in mutant mice. In both Popdc1 and Popdc2 null mutants in mice, a 
bradyarrhythmia phenotype has been described [4]. While at baseline no difference is present between 
mutant and wildtype, subjecting null mutants to physical or mental stress caused sinus pauses, which 
randomly occurred but were strictly stress-dependent [4]. Moreover, for both Popdc1 and -2 mutants, 
phenotype development is age-dependent. Young mutants (3 months old) display a normal chronotropic 
competence, while middle-aged mutant mice (6–8 months old) are severely bradycardic [4]. The  
age-dependency of the stress-induced bradycardia phenotype in these mouse mutants is reminiscent of 
sinus node dysfunction (SND) in man. SND is a leading cause for pacemaker implantation and patients 
with SND, which is prevalent in the elderly, have difficulties to adapt the beating frequency of their 
heart to the physiological demands [20]. It has therefore been hypothesized that some SND patients 
may have abnormal Popdc gene expression or function [4]. Although such data are presently 
unavailable, in failing hearts, the expression levels of POPDC1 and POPDC3 are reduced, however, 
the degree of down-regulation varies between patients [21]. Reduced levels of POPDC1 and POPDC3 
might represent risk factors for the development of sudden cardiac death, atrial fibrillation and other 
conduction disorders, which are prevalent among heart failure patients.  
4. Protein-Protein Interactions of Popdc Proteins 
Our understanding of the molecular function of Popdc proteins is currently limited due to the fact 
that we do not know the protein interaction partners of Popdc proteins. However, two relevant 
interacting proteins have now been identified. 
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4.1. TREK-1 
It has been reported that Popdc proteins interact with the two-pore domain potassium channel 
TREK-1 [4]. This background channel is regulated by a number of physiological stimuli [22]. In the 
heart, TREK-1 is believed to act as a stretch sensor, which possibly modulates atrial natriuretic peptide 
(ANP) secretion [23]. Trek-1 null mutants in mice have a normal lifespan, and no obvious 
morphological or physiological pathology in the heart was reported [24]. Using Xenopus oocytes as a 
heterologous expression system, TREK-1 has been identified as a specific interaction partner of 
Popdc1 [4]. Co-expression of both Popdc1 and TREK-1 results in a current, which is approximately  
2-fold higher than without Popdc1 and probably is caused by an increased membrane presence of 
TREK-1. It is therefore plausible that Popdc proteins modulate TREK-1 trafficking. Importantly, in the 
presence of theophylline, which increases cAMP levels, the effect of Popdc co-expression is abolished 
and no increase in TREK-1 conductivity was observed [4]. Based on the fact that TREK-1 current is 
enhanced in the presence of Popdc1, the null mutant should have a lower level of membrane-localized 
TREK-1. Since TREK-1 acts as a background channel setting the resting membrane potential, a 
reduction of TREK-1 current should lead to a situation in which myocytes would be more excitable, 
however the opposite is observed in the null mutant. Therefore it is likely that also the trafficking of 
other ion channels should depend on the interaction with Popdc proteins and defining these interactions 
might give a clue why Popdc1 and -2 mutants develop a stress-induced bradycardia phenotype.  
4.2. Caveolin-3 
Caveolae are invaginations of the plasma membrane, which are involved in compartmentalization 
and cluster formation of membrane proteins and thereby improving signal transduction [25]. Important 
protein components of caveolae are cavins and caveolins [26]. Caveolin-3 (Cav-3) is the  
muscle-specific isoform, which localizes to the sarcolemma in skeletal muscle fibers and in the plasma 
membrane and t-tubules in cardiac myocytes [27]. Caveolae play various physiological roles, e.g., in 
vesicular trafficking, mechanosensation and transduction, and in signaling processes such as  
β- adrenergic signaling, and therefore in the control of cAMP production [28]. A number of different 
ion channels and transporters have been localized to caveolae in cardiac myocytes including LTCC, 
SCN5A, HCN4, NCX1, and others [29].  
Cav-3 has recently been identified as an interaction partner of Popdc1 [19]. In the absence of 
Popdc1, caveolae in cardiac myocytes were altered in number and size. These alterations might 
contribute to the observed ischaemia/reperfusion vulnerability of Popdc1-null mutant hearts, but may 
also explain in part the cardiac arrhythmia phenotypes in Popdc1 and -2 mutants [19]. In this regard, it 
is noteworthy that Cav-3 was also found to be an interaction partner for CaV1.2 and that caveolae in 
cardiac myocytes foster cluster formation of CaV1.2 and the β2-AR, PKA and AC, thus allowing 
compartmentalized cAMP production and signal transduction [28]. It is therefore possible that  
Popdc proteins, being an interaction partner of Cav-3, are part of this signaling complex. In support of 
this notion it was found that isolated cardiac myocytes of Popdc1 mutants display a reduction in 
[Ca2+]i transients [19]. 
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5. The Other cAMP Effector Proteins 
5.1. Protein Kinase A (PKA) 
PKA is the main effector of cAMP signaling. In its inactive form PKA is a tetramer composed of 
two regulatory (R) and two catalytic (C) subunits. There are four genes encoding regulatory  
subunits (RIα, RIβ, RIIα and RIIβ) and three genes encoding catalytic subunits (Cα, Cβ and Cγ). In the 
absence of cAMP, a dimer of C subunits are bound and suppressed by two R subunits [30]. cAMP 
binds to the R subunits causing a conformational change that relieves the inhibitory effect on the  
C subunits allowing phosphorylation of PKA targets. In the heart, PKA regulates excitation-contraction 
coupling through the phosphorylation of a number of key proteins such as troponin I, ryanodine 
receptor (RyR), phospholamban (PLB) and L-type calcium channels (LTCCs) causing an increase in 
the force (inotropy) and frequency (chronotropy) of the heartbeat and an increase in cardiac relaxation 
(lusitropy) [31]. SAN pacemaking is triggered by the rhythmic release of calcium from the 
sarcoplasmatic reticulum (SR) via the RyR, which is coupled to sarcolemmal currents capable of 
generating periodic action potentials [32]. SAN cells have high basal levels of cAMP and display 
elevated PKA-dependent phosphorylation of phospholamban (PLB) compared with other cardiac cell 
types [33]. In addition, PKA also triggers changes in gene expression through phosphorylation of 
nuclear target proteins such as CREB and HDAC4 and -5 [34–36]. Activation of PKA is 
compartmentalized due to recruitment of PKA to scaffolding proteins (AKAP), which anchor PKA 
close to its phosphorylation targets [37]. Apart from PKA, AKAP proteins bind AC, PDE, protein 
phosphatases, GPCRs and even other cAMP effector proteins and therefore generate macromolecular 
signaling complexes [38].  
5.2. The Exchange Factor Directly Activated by cAMP (EPAC) 
The Exchange Factor Directly Activated by cAMP (Epac) is encoded by two distinct genes Rapgef3 
(Epac1) and Rapgef4 (Epac2) [39]. EPAC proteins are multi-domain proteins, which contain an  
N-terminal regulatory and a C-terminal catalytic region [40,41]. The regulatory region contains a  
high-affinity cAMP-binding domain, while the catalytic region entails a putative guanine nucleotide 
exchange factor (GEF) domain for both Rap1 and Rap2. Studies in neonatal rat cardiac myocytes show 
that an EPAC-selective cAMP agonist (8-pCPT-2'-O-Me-cAMP, 8-CPT) induces an increase in 
spontaneous Ca2+-oscillations [42], while in the adult mouse heart ventricular arrhythmia are  
triggered [43]. The 8-CPT-induced increase in Ca2+ spark frequency is caused by Ca2+/calmodulin-
dependent protein kinase II (CaMKII)-dependent phosphorylation of the RyR [44]. Interestingly, the 
SR Ca2+-leak is triggered by EPAC-2 activation, suggesting isoform-specific roles in myocytes [45]. 
EPAC activation also enhances cell-cell coupling between myocytes through gap junction  
formation [46]. Another aspect of EPAC function is its role in cardiac hypertrophy. 8-CPT treatment  
or forced expression of EPAC-1 causes an increase in cell surface area, protein synthesis, and  
ANF expression and these effects were reversed by shRNA-mediated knockdown of Epac1 [47]. 
Hypertrophy-inducing Epac1 signaling involves small GTPases, phospholipase C (PLC), calcineurin 
and CaMKII, which activate nuclear factor of activated T-cells (NFAT) and myocyte enhancer factor 2 
(MEF2) [48]. 
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5.3. The Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels  
The HCN channels are essential components of cardiac pacemaking in sinuatrial cells and the 
encoded proteins are responsible for a cation current known as If [49]. A unique property of If is the 
activation at a hyperpolarized membrane potential and it is therefore thought that If contributes to the 
pacemaker potential [49]. However there is an emerging consensus that a network of ion channels and 
ion pumps at the plasma membrane and in the sarcoplasmatic reticulum act together to generate the 
oscillating pacemaker action potential [50].  
Of the four HCN channels present in the mammalian genome, three channels (HCN1, HCN2 and 
HCN4) are expressed in the heart [51]. While mutant mice for HCN2 have a relatively mild sinus 
dysrhythmia [52], both HCN1 and HCN4 null mutants display defective cardiac pacemaking [53–55]. 
Loss of HCN4 causes embryonic lethality due to a severe bradycardia [56], while the HCN1 null 
mutant has a postnatal sinus bradycardia [54]. Consistent with the role of HCN channels in cardiac 
pacemaking is the observation that the If antagonist ivabradine, which binds HCN channels in its 
closed state [57], reduces heart rate in heart failure patients [58]. Modeling and biophysical measurements 
have clearly established that cAMP-binding enhances channel opening [59] and therefore this property 
would be the ideal mechanism for triggering the chronotropic response after adrenergic stimulation. 
However, a number of reports in the literature demonstrate that pacemaking in adult mice harboring 
cAMP-binding site mutations in HCN4 retain the ability to respond to sympathetic stimulation, while 
embryonic hearts can only accelerate heart rate in the presence of a functional cAMP-binding site in 
HCN4 [60,61]. Data in patients either support [62], or refuse a role of If in the autonomous control of 
pacemaking [63]. There is also evidence that HCN4 is a PKA substrate and that inhibition of PKA 
significantly reduces the ability of beta-adrenergic agonists to shift the voltage dependence of If in 
isolated sinuatrial myocytes [64]. Thus, it is gradually emerging that different elements of the cAMP 
signal transduction pathway in sinuatrial myocytes act in parallel to mediate the adrenergic control of 
cardiac pacemaking. 
6. Conclusions  
The Popdc gene family is associated with cAMP signaling and therefore is part of the network of 
cAMP effector proteins. HCN channels and Popdc proteins display tissue-specific expression in the 
heart, while the other two cAMP effector proteins are more widely expressed. In particular the various 
elements of the cardiac conduction system display high-level expression of HCN1 and HCN4 [51] and 
Popdc1 and Popdc2 [4]. Thus, adrenergic control of the cardiac pacemaking and conduction may in 
particular be regulated via HCN channels and Popdc proteins. However, both PKA and EPAC also 
have their inputs in particular by modulating calcium release from the SR through the RyR2 [39] and 
calcium uptake through phosphorylation of PLB [33].  
We probably need to consider that the evaluation of gene function by knockout approaches alone 
has its limitation when confronted with a complex network of protein families with redundant and 
overlapping functions. In case of Popdc proteins, we have, on the one hand, functional redundancy due 
to the presence of three Popdc proteins with overlapping expression pattern and similar if not identical 
functions [4]. In addition, however, there is also overlap in function at the level of the different cAMP 
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effector proteins. Thus chronotropism of the cardiac pacemaker may involve the simultaneous 
activation of all four cAMP-binding proteins and therefore the loss of a single gene in one of the 
cAMP effector classes is compensated to a large extent by the remaining protein network.  
However, if this assumption is correct, why vertebrates have maintained the same number of Popdc 
genes? An accidental loss of a gene encoding one of the mediator genes would be largely compensated 
and should be without severe consequences. A possible answer to this question might be that the heart 
has a vital role for a successful completion of the fight or flight response. Possibly, the speed with 
which the system can respond is key to the specific roles of Popdc proteins. Speed is undoubtedly an 
essential determinant of success in the fight or flight response. Since Popdc proteins have a high 
affinity for cAMP and are abundantly present in cardiac cells makes them ideally suited to mediate a 
rapid response to rising cAMP levels [4].  
Thus in addition to the characterization of different animal models with a gain- and loss-of-Popdc 
gene function, it will be important to identify also small molecules, which are specific to the different 
cAMP effector proteins. These will assist in determining the specific functions of each cAMP effector 
protein. Such agonists and antagonists already exists for PKA [65], EPAC [66] and were recently 
discovered also for HCN channels [67]. Such small molecules represent important tools for advancing 
our knowledge of the different functions of the various cAMP effector proteins and would in particular 
advance our knowledge of the function of Popdc proteins in the heart.  
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